Multiple faces of a pandemic
reflections on COVID-19 in the Brazilian scenario
DOI:
https://doi.org/10.26512/gs.v11i3.32112Keywords:
Pandemias. Sistema Único de Saúde. Saúde Pública. Grupos de Risco.Abstract
The pandemic of the new coronavirus (COVID-19) quickly impacted health systems and the world economy, becoming the greatest health crisis of the modern age. It started with an outbreak in Wuham, China and has assumed unimaginable proportions, generating political and academic discussions in the form of coping, in addition to the panic generated by the population due to the severity of its effects. The present study is a theoretical article carried out through a non-systematic literature review, which seeks to point out the main characteristics of the virus and its reflexes, mainly in Brazil. As in other countries, the Brazilian health system is strongly affected, requiring an intense mobilization of governmental administrations in all spheres. In this sense, the need to strengthen and adequately finance the Unified Health System to combat health crises is emphasized, given the progressive scrapping that it has been suffering in recent years. Equally important, it is the contextualization of interventions by managers, where scientific knowledge presents itself as a strong ally in facing the pandemic, strengthening the SUS, and guidance for Brazilian public management.
Downloads
References
Referências
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet. 2020;395(10229):1054-62.
Liu Y, Gayle AA, Wilder-Smith A, Rocklöv J. The reproductive number of COVID-19 is higher compared to SARS coronavirus. J. Travel Med.2020;27(2):1-4.
Zhang T,Wu Q,Zhang Z. Probable pangolin origin of SARS-CoV-2 associated with the COVID-19 outbreak. Current Biology.2020;30(7):1346-51.
CucinottaD,VanelliM. WHO declares COVID-19 a pandemic. Acta Bio Med. 2020;91(1):157-60.
Remuzzi A,Remuzzi G. COVID-19 and Italy: what next? The Lancet. 2020;395(10231):1225-28.
Andersen KG, Rambaut A, Lipkin WI, Holmes EC, Garry RF. The proximal origin of SARS-CoV-2. Nature medicine. 2020;26(4):450-52.
Tuñas ITC, Silva ET, Santiago SBS, Maia KD, Silva-Júnior GO. Doença pelo Coronavírus 2019 (COVID-19): Uma abordagem preventiva para Odontologia. Rev. Bras. Odontol. 2020; 77:1-6.
Ren LL, Wang YM, Wu ZQ, Xiang ZC, Guo L, Xu T, et al. Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study. Chin Med J. 2020;133(9):1015-24.
Li Q, Med M, Guan X, Wu P, Wang X, Zhou L. Early transmission dynamics in Wuhan, China, of novel coronavirus”“infected pneumonia. N Engl J Med. 2020;382:1199-1207
Dolce Filho R,Nechar RC,Ribeiro Filho A. Estudo preliminar de sintomas e medicamentos prevalentes do gênio epidêmico da pandemia de COVID-19 no brasil. Organização Pan-Americana da Saúde [Internet]. 2020 [citado 2020 jun 10]. Disponível em:https://covid19-evidence.paho.org/handle/20.500.12663/1130
World Health Organization. Coronavirus disease 2019 (COVID-19): situation report - 72.World Health Organization [serial on the Internet]. 2020 [cited 2020 jun 3]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports
Gao J, Tian Z,Yang X. Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. BioScience. 2020.14(1):72-3.
Gautret P, Lagier JC, Parola P, Hoang VT, Meddeb L, Mailhe M, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int. J. Antimicrob. Agents [serial on the Internet]. 2020[cited 2020 may 29]. Available from: https://www.medrxiv.org/content/10.1101/2020.03.16.20037135v1
Imoto AM, Gottems LBD, Branco HPC, Santana LA, Monteiro OLR, Fernandes SES, et al. Cloroquina e Hidroxicloroquina no tratamento da COVID-19. Com. Ciências Saúde. 2020;31(Suppl 1):17-30.
Pacheco RL, Pachito DV, Bagattini AM, Riera R. Hidroxicloroquina e cloroquina para COVID-19. Sírio-Libanês [Internet]. 2020 [citado 2020 jun 01]. Disponível em: https://oxfordbrazilebm.com/wpcontent/uploads/2020/04/RS_rapida_hidroxicloroquina_COVID19_atualizacao_19_04_20.pdf
Menezes CR, Sanches C,Chequer FMD. Efetividade e toxicidade da cloroquina e da hidroxicloroquina associada (ou não) Ã azitromicina para tratamento da COVID-19. O que sabemos até o momento? J. Health BiolSci. 2020;8(1):1-9.
Oliveira ES, Matos MF, Cavalcanti OSS, Morais ACLN. Uso off label de antimaláricos em pacientes portadores de COVID-19. Res., Soc. Dev. 2020;9(6):1-13.
Gates, B. Responding to COVID-19- A once-in-a-centurypandemic? NEngl J Med. 2020;382:1677-79.
Spinelli A,PellinoG. COVID-19 pandemic: perspectives on an unfolding crisis. Br J Surg [serial on the Internet]. 2020 [cited 2020 jun 03]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7228411/pdf/BJS-9999-na.pdf
McKibbin WJ,Fernando R. The global macroeconomic impacts of COVID-19: Seven scenarios. CAMA Working Paper. 2020;(19):1-41.
Bedford J, Enria D, Giesecke J, Heymann DL, Ihekweazu C, Kobinger G, et al. COVID-19: towards controlling of a pandemic. The Lancet. 2020;395(10229):1015-18.
Applegate WB,Ouslander JG. COVID”19 Presents High Risk to Older Persons. J Am Geriatr Soc. 2020;68(4):681.
Li W, Yang Y, Liu ZH, Zhao YJ, Zhang Q, Zhang L, et al. Progression of mental health services during the COVID-19 outbreak in China. Int J Biol Sci. 2020;16(10):1732-38.
Smith AC, Thomas E, Snoswell CL. Telehealth for global emergencies: Implications for coronavirus disease 2019 (COVID-19).J Telemed Telecare. 2020;26(5):309-13.
Aveni A. Sistemas de Saúde e Economia da Saúde ”“ Impactos Causados pela COVID-19. Cadernos Prospecção. 2020;13(2):477-93.
Hollander JE, CarrBG. Virtually perfect?Telemedicine for COVID-19. N Engl J Med. 2020;382:1679-81.
RotherET. Revisão sistemática X revisão narrativa. Acta paul. enferm. 2020;20(2):v-vi.
Bardin L. Análise de Conteúdo. 4ª ed. Lisboa: Edições 70; 2009.
Fang L,Karakiulakis G,Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? The Lancet. 2020;8(4):e21.
Koh D. Occupational risks for COVID-19 infection. Occup Med. 2020;70(1):3-5.
Guo W, Li M, Dong Y, Zhou H, Zhang Z, Tian C, et al. Diabetes is a risk factor for the progression and prognosis of COVID”19. Diabetes Metab Res Rev. 2020;1-9.
Lippi G,Wong J,Henry BM. Hypertension and its severity or mortality in Coronavirus Disease 2019 (COVID-19): a pooled analysis. Pol Arch Intern Med. 2020;130(4):304-9.
Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA cardiology [serial on the Internet]. 2020 [cited 2020 jun 13]. Available from: https://jamanetwork.com/journals/jamacardiology/article-abstract/2763524
Li B, Yang J, Zhao F, Zhi L, Wang X, Liu L, et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol. 2020;109:531-8.
Guo T, Fan Y, Chen M. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiology [serial on the Internet]. 2020 [cited 2020 jun 13]. Available from: https://jamanetwork.com/journals/jamacardiology/article-abstract/2763845
Qiao J. What are the risks of COVID-19 infection in pregnant women? The Lancet. 2020;395(10226):760-2.
Adams JG, WallsRM. Supporting the health care workforce during the COVID-19 global epidemic. JAMA. 2020;323(15):1439-40.
Klompas M, Morris CA, Sinclair J, Pearson M, Shenoy ES. Universal masking in hospitals in the COVID-19 Era. N Engl J Med. 2020;382:e63.
Jordan RE,Adab P,Cheng KK. COVID-19: risk factors for severe disease and death. BMJ. 2020;368:m1198.
Rodriguez-Morales AJ, Gallego V, Escarela-Antezana JP, Méndez CA, Zambrano LI, Franco-Paredes C, et al. COVID-19 in COVID-19 in Latin America: The implications of the first confirmed case in Brazil. Travel Med Infect Di. 2020;(101613):1-4.
Croda JHR,Garcia LP. Resposta imediata da Vigilância em Saúde à epidemia da COVID-19. Epidemiol. Serv. Saúde. 2020;29(1):1-3.
Ministério da Saúde. 06 Boletim epidemiológico ”“ Centro de Operações de Emergências em Saúde Pública. Ministério da Saúde [Internet]. 2020 [citado 2020 jun 16]. Disponível em: https://portalarquivos.saude.gov.br/images/pdf/2020/April/03/BE6-Boletim-Especial-do-COE.pdf
Ministério da Saúde. 17 boletim epidemiológico especial COE-COVID-19. Ministério da Saúde [Internet]. 2020 [citado 2020 jun 16]. Disponível em: https://www.saude.gov.br/images/pdf/2020/May/29/2020-05-25---BEE17---Boletim-do-COE.pdf
Ministério da Saúde. Brasil registra 2.915 casos confirmados de coronavírus e 77 mortes. Ministério da Saúde [Internet]. 2020 [citado 2020 maio 30]. Disponível em: https://www.saude.gov.br/noticias/agencia-saude/46610-brasil-registra-2-915-casos-confirmados-de-coronavirus-e-77-mortes
Emer C, Maia KP, Santana PC, Silva DGM, Cosmo LG, Assis APA, et al. Vulnerabilidade das microrregiões da Região Sul do Brasil à pandemia do novo coronavírus (SARS-CoV-2).ScieloPreprints [Internet]. 2020 [citado 2020 maio 29]. Disponível em: https://preprints.scielo.org/index.php/scielo/preprint/view/128
Freitas ARR,Napimoga M,Donalisio MR. Análise da gravidade da pandemia de COVID-19. Epidemiol. Serv. Saúde. 2020;29(2):1-5.
Platero K, Gomes F. Números estatísticos e realidades: Uma proposta de reflexão sobre a pandemia de COVID-19 no Brasil. Dilemas. 2020:1-11.
Brasil.CONORAVÃRUS Brasil. Painel Coronavírus 16.06.2020. Ministério da Saúde [Internet]. 2020 [citado 2020 jun 16]. Disponível em: https://covid.saude.gov.br/
Barreto ML, Barros AJD, Carvalho MS, Codeço CT, Hallal PRC, Medronho RA, et al. O que é urgente e necessário para subsidiar as políticas de enfrentamento da pandemia de COVID-19 no Brasil?Ver. bras. Epidemiol. 2020;23:1-4.
Croda J, Oliveira WK, Frutuoso RL, Mandetta LH, Baia-da-Silva DC, Brito-Souza JD, et al. COVID-19 in Brazil: advantages of a socialized unified health system and preparation to contain cases. Rev. Soc. Bras. Med. Trop. 2020;53:1-6.
Oliveira ES,Morais ACLN. COVID-19: uma pandemia que alerta à população. InterAm J Med Health. 2020;3:1-7.
Baptista AB,Fernandes LV. COVID-19, análise das estratégias de prevenção, cuidados e complicações sintomáticas. Revista Desafios. 2020;7(Supl3):38-47.
Netto Ferreira RG,CorrêaJWN. Epidemiologia do surto de doença por coronavírus(COVID-19). Revista Desafios. 2020;7(Supl 3):18-25.
Ceccon RF, Schneider IJC. Tecnologias leves e educação em saúde no enfrentamento à pandemia da COVID-19. ScieloPreprint [Internet]. 2020 [citado 2020 jun 7]. Disponível em: https://preprints.scielo.org/index.php/scielo/preprint/view/136
Sousa Júnior JH, Raasch M, Soares JC, Ribeiro LVHAS. Da Desinformação ao Caos: uma análise das Fake News frente à pandemia do Coronavírus (COVID-19) no Brasil. Cadernos Prospecção. 2020;13(2):331-46.
Buckeridge MS. Global analysis of the infection by COVID-19. Ambient. soc. 2020;23:1-8.
Dowd JB, Rotondi V, Andriano L, Brazel DM, Block P, Ding XD, et al. Demographic science aids in understanding the spread and fatality rates of COVID-19. Proc Natl Acad Sci. 2020;117(18):9696-98.
Nepomuceno MR, Acosta E, Alburez-Gutierrez D, Aburto JM, Gagnon A, Turra CM. Besides population age structure, health and other demographic factors can contribute to understanding the COVID-19 burden. Proc Natl Acad Sci. 2020;117(25):13881-3.
Facchini LA. COVID-19: Nocaute do neoliberalismo? Será possível fortalecer os princípios históricos do SUS e da APS em meio à pandemia? APS em Revista. 2020;2(1):3-10.
Lopez FG, Palotti PLM, Barbosa SCT, Koga NM. Mapeamento dos profissionais de saúde no Brasil: alguns apontamentos em vista da crise sanitária da COVID-19. Brasília/DF: Instituto de Pesquisa Econômica Aplicada; 2020.
Ferreira Júnior RR,Santa Rita LP. Impactos da COVID-19 na Economia: limites, desafios e políticas. CadernosProspecção. 2020;13(2):459-76.
Giovanella L. APS na rede de enfrentamento à COVID-19. ENSP/Fiocruz [Internet]. 2020 [citado 2020 jun 01]. Disponível em: https://www.arca.fiocruz.br/handle/icict/40918
Garcia LP, Duarte E. Intervenções não farmacológicas para o enfrentamento à epidemia da COVID-19 no Brasil. Epidemiol. Serv. Saude. 2020;29(2):1-4.
Machado MH. Profissionais de saúde em tempos de COVID-19:SUS e trabalhadores da área são patrimônio do país. O Globo [Internet]. 2020 [citado 2020 jun 05]. Disponível em: https://www.arca.fiocruz.br/bitstream/icict/40850/3/Profissionais_Saude_Tempos_COVID_19_JORNAL.pdf
Verbeek JH, Rajamaki B, Ijaz S, Sauni R, Toomey E, Blackwood B, et al. Personal protective equipment for preventing highly infectious diseases due to exposure to contaminated body fluids in healthcare staff. Cochrane Database [Internet]. 2020 [cited 2020 jun05];(4):CD011621.Available from:https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011621.pub4/abstract
Ujvari SC. Pandemias: a humanidade em risco. São Paulo: Contexto; 2011.
Nedel FB. Enfrentando a COVID-19: APS forte agora mais que nunca!APS emRevista. 2020;2(1):11-6.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 ELECTRONIC JOURNAL MANAGEMENT AND HEALTH
![Creative Commons License](http://i.creativecommons.org/l/by-nd/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
I declare that this article is original and has not been submitted for publication in any other national or international journal, either in whole or in part. I further declare that once published in the Electronic Journal Management and Health published by the University of Brasília, it will never be submitted by me or any of the other coauthors to any other means of scientific dissemination.
Through this instrument, in my name and in the name of the other coauthors, may I soon copy the copyright of the article to Electronic Journal Management and Health and declare that I am aware that failure to comply with this commitment will subject the violator to penalties and penalties Law of Protection of Rights Authorities (Nº9609, of 02/19/98).